Top Markets
Coin of the day
Oragenics, Inc. Oragenics, Inc.

Oragenics, Inc.

OGEN
株式のランク #36713
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on... Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. Beyond its infectious disease focus, Oragenics also has other experimental treatments under development, including LPT3-04, targeting weight loss, and SMaRT Replacement Therapy, a topical solution aimed at preventing dental cavities. Strategic alliances are also a part of its operations. This includes a licensing deal with Noachis Terra Inc. for patents and biological resources related to pre-fusion coronavirus spike proteins. Additionally, Oragenics is collaborating with Precigen, Inc. and ILH Holdings, Inc. on the advancement and market introduction of MU1140 and its associated compounds. Established in 1996, the company, formerly known as Oragen, Inc., maintains its headquarters in Tampa, Florida.
株価
$0.5301
最終同期: 2026-08-14
時価総額
$2.39M
変化(1日)
0.00%
変化(1年)
-53.90%
US
取引 Oragenics, Inc. (OGEN)

カテゴリー

Oragenics, Inc.(OGEN)の株価履歴
終値の最高値: $0.53 (2026-08-01)

終値の最安値: $1.08M (2003-07-01)
Oragenics, Inc. の株価履歴(2003 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -2.01%
2025 -92.01%
2024 -92.61%
2023 -50.48%
2022 -65.96%
2021 7.57%
2020 -16.69%
2019 -44.73%
2018 -66.89%
2017 -49.72%
2016 -58.32%
2015 53.42%
2014 -69.17%
2013 35.84%
2012 46.62%
2011 -58.54%
2010 -35.31%
2009 -12.86%
2008 -26.00%
2007 -61.09%
2006 110.38%
2005 -85.73%
2004 -5.16%
2003 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE